Peter Mac provides a world-class research education program at a leading Australian cancer research institution for students from Australian and international universities.
The Peter Mac research education program provides opportunities for students to develop knowledge and expertise in their chosen research area, as well as developing professional skills that will help them fulfil their career ambitions. Read more information about our postgraduate program.
View the VIRTUAL Research Student Open Day introduction video to find out how you can get involved in our research in 2021 . For information about all projects on offer see: 2021 student project booklet
Hear directly from some of our supervisors about their research projects on offer for 2021 below
The Brown lab investigates the ways in which aberrant cellular metabolism contributes to malignant transformation, tumour progression and therapy resistance in cancer. This knowledge is applied to the pre-clinical development of novel and more effective interventions for cancer therapy.
The National Centre for Infections in Cancer (NCIC) was conceived in response to data on infections in cancer patients being a leading cause of death and a significant cost to the healthcare system.
Our research group aims to optimise patient outcomes using a health services approach to prevent and manage the critical and growing problems of healthcare associated and antibiotic resistant infection, poor sepsis and antimicrobial management and late recognition of infection in this vulnerable population.
The Neeson Laboratory explores the human immune system responses to tumour development and to immunotherapy. We do this using patient samples from cohort studies or clinical trials. Having made observations in these samples, we then explore immunotherapy drug combination mechanism of action in model systems to provide new information for rational use of these drugs in the clinic.
The Parker laboratory explores interactions in the cancer microenvironment that prevent or support tumour invasion and spread (metastasis) to other tissues, including bone. Our overall objective is to uncover new biomarkers (genes/proteins) that predict risk of cancer metastasis and response to therapy and uncover novel precision therapeutic strategies to target the most lethal stages of solid cancer progression at an individual patient level. Our investigations integrate innovative science and pre-clinical research to inform the translation of agents into clinical trial.
We explore how blood cell signalling influences fate decisions during development and immune responses. This will help to improve immunotherapies for cancer and infectious diseases, and to understand how leukaemia occurs when development goes wrong. Key for our research approach is to develop and apply new imaging and computational approaches; for this reason, the lab is partly located in the Centre for Micro-Photonics, Swinburne University.
In the Voskoboinik Killer Cell Biology Laboratory, researchers investigate the regulation and function of cytotoxic T lymphocytes (CTL) and natural killer (NK) cells, which play a key role in the surveillance of virus-infected and cancer cells. Clarifying the biology of CTL and NK cells is critical to help understand the fundamental principles of immunity, predisposition to paediatric blood cancers and immune deficiency. We take a multidisciplinary approach that encompasses immunology, biochemistry, structural biology, cell biology and genetics.
For more information about the available projects refer to the
Contact: A/Prof. Ilia Voskoboinik [email protected]
The Wickramasinghe laboratory uses cutting-edge cell biology, molecular biology and genetic approaches to understand a critical step in gene expression, messenger RNA export. Nuclear export of mRNA to the cytoplasm is required for gene expression and is deregulated in cancer. Our ultimate goal is to use these fundamental biological insights to develop novel first-in-class inhibitors to treat cancer.